PATENT CLAIM ANALYSIS

Application Number: 16108727
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "249000"]

Abstract:
The invention generally relates to compositions for inducing vasoconstriction. The compositions comprise highly selective alpha-2 adrenergic receptor agonists, at low concentrations, such as below 0.05% weight by volume. The compositions preferably comprise brimonidine. The compositions preferably have pH from about 4.0 to about 7.5.

Claim (Index 15):
A method of treating septic, toxic, or anaphylactic shock comprising administering to a subject in need thereof a composition comprising brimonidine, wherein brimonidine is administered via subcutaneous or intramuscular injection at a concentration from about 0.01% to about 0.05% w/v or via intravenous injection at a concentration from about 0.0001% to about 0.01% w/v, wherein w/v denotes weight by total volume of the composition.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.37838
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12460968', '12460970', '12460941', '12460942', '14044929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7967088424437938
- 35 USC 102 Novelty (BERT): 0.59026393204081
- Combined Prediction Score: 0.7760643514034954
- Mean Citation Score: 482.61016
- Max Citation Score: 522.8359
- Similarity Product: 418.9477466032386

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test